Resmed Inc. buy The Goldman Sachs Group, Inc.
Start price
16.01.25
/
50%
€228.00
Target price
16.01.26
-
Performance (%)
-2.81%
End price
17.01.26
€221.60
Summary
This prediction ended on 17.01.26 with a price of €221.60. With a performance of -2.81%, the BUY prediction for Resmed Inc. by The_Goldman_Sachs_Gr closed slightly in the red. Dividends of €0.51 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -7.251% | -7.251% | -0.148% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten